Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Indian J Exp Biol ; 1994 Oct; 32(10): 694-7
Artículo en Inglés | IMSEAR | ID: sea-57805

RESUMEN

A herbal hepatoprotective formulation Liv 52 down regulated the tumour necrosis factor (TNF) production in Charles Foster Rats treated with CCl4. Inhibition of TNF activity was proportional to the hepatoprotective activity.


Asunto(s)
Animales , Intoxicación por Tetracloruro de Carbono/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Combinación de Medicamentos , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Extractos Vegetales/farmacología , Plantas Medicinales , Ratas , Factor de Necrosis Tumoral alfa/biosíntesis
2.
Indian J Exp Biol ; 1992 Aug; 30(8): 696-700
Artículo en Inglés | IMSEAR | ID: sea-56624

RESUMEN

Administrations of hepatotoxicants namely carbon tetrachloride (CCl4:0.4 ml in 1.2 ml of liquid paraffin) and ANIT (1 ml of 1.5% solution in liquid paraffin) in Charles foster rats (force fed) and D-galactosamine (8 mg in water per swiss albino mouse, ip) induce the release of TNF-alpha in case of CCl4 and D-galactosamine. High TNF-alpha level was observed up to 48 hr in CCl4 and up to 24 hr in D-galactosamine treated animals. Elevated levels of biochemical like ALP and SGPT are also recorded. TNF-alpha level can be measured of tissue damage and prognosis in case of hepatitis.


Asunto(s)
1-Naftilisotiocianato/farmacología , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Animales , Tetracloruro de Carbono/farmacología , Galactosamina/farmacología , Hígado/efectos de los fármacos , Ratones , Ratas , Factor de Necrosis Tumoral alfa/biosíntesis
3.
Indian J Physiol Pharmacol ; 1987 Jan-Mar; 31(1): 25-9
Artículo en Inglés | IMSEAR | ID: sea-108497

RESUMEN

'Arogyavardhini'-an indigenous formulation was evaluated for its hepatoprotective activity in rats, using two models of carbon tetrachloride (CCl4) hepatic damage, one simulating vital hepatitis and the other simulating fatty change. The protective effect was assessed from serum aspartate transaminase (AST) and alkaline phosphatase levels and from histopathological changes in liver. The results revealed that 'Arogyavardhini' (5 mg/100g, PO daily) was effective in minimizing the changes in serum levels of AST and alkaline phosphatase induced by CCI. The protective effect was also evident on histopathological examination.


Asunto(s)
Fosfatasa Alcalina/sangre , Animales , Aspartato Aminotransferasas/sangre , Intoxicación por Tetracloruro de Carbono/prevención & control , Combinación de Medicamentos/farmacología , Hígado Graso/prevención & control , Hepatitis Viral Animal/prevención & control , Hígado/efectos de los fármacos , Masculino , Medicina Ayurvédica , Metales/farmacología , Extractos Vegetales/farmacología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA